Ten years ago, my husband Sergio was diagnosed with advanced lung cancer at age 65. He refused the only treatment offered to ...

Adjuvant treatment with Alecensa (alectinib) elicited a 4-year overall survival (OS) rate of 98.4% for patients with resected ALK-positive early stage non–small cell lung cancer (NSCLC) according to ...

On Tuesday, October 7, dozens of local healthcare providers gathered with the American Lung Association in South Carolina to discuss the latest advancements in lung cancer identification and treatment ...

According to the American Cancer Society, in 2025, there have been about  226,650 new cases of lung cancer and nearly 124,730 deaths from lung cancer. It’s a ...

In August 2025, the FDA gave accelerated approval to Hernexeos for patients with previously treated metastatic or ...

Groundbreaking research reveals mRNA COVID-19 vaccines may significantly boost cancer treatment. A study found patients ...

AstraZeneca Plc and Daiichi Sankyo Co.’s cancer drug Enhertu bolstered outcomes for patients with early-stage breast cancer, ...

Artificial Intelligence is revolutionising oncology from detecting cancer earlier and faster to designing personalised therapies. But can it really make cancer curable? Dr. Sunil Kumar Puri, Director ...

A study found that covid-19 vaccines appeared to awaken the immune system in lung and skin cancer patients, helping them live ...

Early screening among high-risk groups can lead to earlier detection, better prognosis and higher success rates for curative ...

New research suggests Covid-19 mRNA vaccines offer benefits beyond viral protection. These vaccines may boost the immune ...

A local mom denied medicine for late-stage breast cancer even though the treatment was working. Her doctor couldn't get the ...